FDA inspection
Dishman Carbogen Amcis Limited: FDA inspection ending Jun 12, 2025
FDA inspection 1275944 · No Action Indicated (NAI) · Ahmedabad
Key facts
| Inspection ID | 1275944 |
|---|---|
| Firm | Dishman Carbogen Amcis Limited |
| FEI number | 1000607691 |
| Address | 1216/11 - 12 - 1216/20 - 26 Phase Iv, Gidc Estate |
| City | Ahmedabad |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Jun 12, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data